Compounds > 4,5,6,7-tetrabromo-2-azabenzimidazole

4,5,6,7-tetrabromo-2-azabenzimidazole and cyclin d1

4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alinger, B; Berr, F; Di Fazio, P; Fuereder, J; Kiesslich, T; Neureiter, D; Oberdanner, C; Ocker, M; Pichler, M; Wachter, J	1

Other Studies

1 other study(ies) available for 4,5,6,7-tetrabromo-2-azabenzimidazole and cyclin d1

Article	Year
Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells. International journal of biological sciences, 2012, Volume: 8, Issue:1 Topics: Antineoplastic Agents; Benzimidazoles; beta Catenin; Biliary Tract Neoplasms; Cadherins; Cell Line, Tumor; Cell Survival; Clinical Trials as Topic; Cyclin D1; Flavonoids; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Quercetin; RNA, Messenger; Sulfonamides; Triazoles; Vimentin; Wnt Signaling Pathway	2012

Article

Year

Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.

International journal of biological sciences, 2012, Volume: 8, Issue:1

Topics: Antineoplastic Agents; Benzimidazoles; beta Catenin; Biliary Tract Neoplasms; Cadherins; Cell Line, Tumor; Cell Survival; Clinical Trials as Topic; Cyclin D1; Flavonoids; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Quercetin; RNA, Messenger; Sulfonamides; Triazoles; Vimentin; Wnt Signaling Pathway

2012